Findings revealed that only cells from the rare CD34+/CD4− and CD34+/CD7− subfractions could engraft T-ALL in mice, suggesting that pediatric T-ALL originates from cells with a primitive immunophenotype, similar to what is observed in AML [131]. This evidence concerns the gene CD34 and acute lymphoblastic leukemia.